Conference - The future of ARVs in Africa
2nd Southern African HIV Clinicians Society (SAHCS) long-acting treatment and prevention conference entitled ‘The future of antiretrovirals in Africa: Long-acting agents and beyond’ was held on Tuesday, 29 October 2024 at The Maslow Hotel in Sandton.
The conference focused on long-acting treatment and prevention, with programme sessions including outcomes of implementation studies, prevention studies, and treatment studies.
The event provided healthcare professionals with up-to-date clinical knowledge and clinical skills development around patient treatment, care and support.
View the programme - Click here
Conference presentations:
Long-acting agents - where do these products fit in the African context? | Dr Catherine Orrell
Lenacapavir, a novel capsid inhibitor for HIV treatment and prevention | Prof Francois Venter
From trial to implementation – can IMPALA help us jump across the gap? | Dr Nigel Garrett
What are the treatment options for patients with multidrug-resistant HIV-1 infection? | Dr Mohammed Rassool
What is the role of lenacapavir in future first-line HIV treatment? | Prof Francois Venter
How long-acting injectable ART could help adolescent and young adults | Dr Lauren Jennings
Pre-exposure prophylaxis in adolescent girls and young women at risk of HIV infection | Dr Nkosiphile Ndlovu
Uptake and retention of adolescents and young adults in differentiated HIV prevention | Prof Maryam Shahmanesh
LA medications: Where do they fit in for niche populations in an African context? | Prof Lee Fairlie
Long-acting PrEP in Pregnancy and Breastfeeding | Dr Dvora Joseph Davey
Advancements in Neonatal HIV Therapy | Dr Adrie Bekker
Progress towards bringing Long-acting ART to children and adolescents | Mo Archary
Assessing the demographic, risk profile, and clinical characteristics of early PrEP adopters | Dr Pippa Macdonald
PrEP LA implementation in Botswana | Dr Ava Avalos
Support for the 2nd SAHCS long-acting treatment and prevention conference has been provided by the following:
Previous conference information:
The 1st SAHCS long-acting treatment and prevention conference, hosted on 20 September 2022 at Indaba Hotel in Fourways, was filled with brilliant presentations from top HIV-experts with a highly engaged audience and powerful discussions - there may be barriers but if we all come together and deliver scientific solutions through a person-centered approach alongside statutory support we can curb this HIV epidemic!20 September 2022 - Conference programme – download here
Conference presentations:
- Islatravir (MK-8591) - NRTTI | Dr Bronywyn Bosch
- Long-Acting Injectables and resistance in the South African context | Dr Bronywyn Bosch
- Long-acting agents and beyond for the children and adolescents with HIV | Prof Mo Archary
- Guideline considerations for LAIs: How should Africa be thinking about this? | Prof Francois Venter
- Cabotegravir as PrEP: Lessons from HPTN 083 and HPTN 084 | Dr Carrie-Anne Mathew